Striatal Dopaminergic Metabolism and DAT Density in Young Onset Parkinson's Disease Patients: a PET Study with [18F]fluoro-L-DOPA and [11C]PE2I Using Two Methods of Analysis

被引：0
|
作者：
Santiago-Ribeiro, M. J. [1 ]
Lohmann, E. [2 ]
Brice, A. [2 ]
Dolle, F. [1 ]
Laurier, L. [1 ]
Syrota, A. [1 ]
Remy, P. [3 ,4 ]
机构：
[1] CEA, Serv Hosp Frederic Joliot, DRM, DSV, F-91406 Orsay, France
[2] Hop La Pitie Salpetriere, Paris, France
[3] URA CEA CNRS 2210, Creteil, France
[4] CHU Henri Mondor, F-94010 Creteil, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 35 条
  • [1] Striatal and extrastriatal dysfunction in Parkinson's disease with dementia:: a 6-[18F]fluoro-L-dopa PET study
    Ito, K
    Nagano-Saito, A
    Kato, T
    Arahata, Y
    Nakamura, A
    Kawasumi, Y
    Hatano, K
    Abe, Y
    Yamada, T
    Kachi, T
    Brooks, DJ
    BRAIN, 2002, 125 : 1358 - 1365
  • [2] Striatal and extrastriatal dysfunction in Parkinson's disease with dementia. A 6-[18F]fluoro-l-dopa PET study
    Ito, K
    Nagano-Saito, A
    Kato, T
    Arahata, Y
    Nakamura, A
    Kawasumi, Y
    Hatano, K
    Abe, Y
    Yamada, T
    Kachi, T
    Brooks, DJ
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1089 - 1089
  • [3] Rate of progression in Parkinson's disease:: A 6-[18F]fluoro-L-dopa PET study
    Nurmi, E
    Ruottinen, HM
    Bergman, J
    Haaparanta, M
    Solin, O
    Sonninen, P
    Rinne, JO
    MOVEMENT DISORDERS, 2001, 16 (04) : 608 - 615
  • [4] Striatal D2 dopamine receptor status in Parkinson's disease:: An [18F]dopa and [11C]raclopride PET study
    Dentresangle, C
    Veyre, L
    Le Bars, D
    Pierre, C
    Lavenne, F
    Pollak, P
    Guerin, J
    Froment, JC
    Brousolle, E
    MOVEMENT DISORDERS, 1999, 14 (06) : 1025 - 1030
  • [5] Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-11C]DOPA and [18F]FE-PE2I in humans
    Suzuki, Masayuki
    Ito, Hiroshi
    Kodaka, Fumitoshi
    Takano, Harumasa
    Kimura, Yasuyuki
    Fujiwara, Hironobu
    Sasaki, Takeshi
    Takahata, Keisuke
    Nogami, Tsuyoshi
    Nagashima, Tomohisa
    Nengaki, Nobuki
    Kawamura, Kazunori
    Zhang, Ming-Rong
    Varrone, Andrea
    Halldin, Christer
    Okubo, Yoshiro
    Suhara, Tetsuya
    NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (03) : 231 - 237
  • [6] Longitudinal combined 11C UCB J and 18F FE PE2I PET imaging of presynaptic terminal loss in early Parkinson's disease
    Delva, A.
    Van Laere, K.
    Vandenberghe, W.
    MOVEMENT DISORDERS, 2022, 37 : S67 - S67
  • [7] Striatal and extrastriatal dysfunction in Parkinson's disease with dementia:: a 6-[18F]fluoro-L-dopa PET study (vol 125, pg 1358, 2002)
    Ito, K
    Nagano-Saito, A
    Kato, T
    Arahata, Y
    Nakamura, A
    Kawasumi, Y
    Hatano, K
    Abe, Y
    Yamada, T
    Kachi, T
    Brookes, DJ
    BRAIN, 2002, 125 : 2144 - 2144
  • [8] Striatal dopamine transporter availability and D2 receptor density correlate to relative blood flow measured with [11C]PE2I, [18F]FE-PE2I and [11C]raclopride PET
    Jonasson, M.
    Fazio, P.
    Frick, A.
    Appel, L.
    Laurell, G. L.
    Danfors, T.
    Fredrikson, M.
    Furmark, T.
    Varrone, A.
    Lubberink, M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 544 - 544
  • [9] Effect of striatal dopaminergic denervation on [18F]FDOPA-, [11C]DTBZ-, and [11C]MP-PET scans: A comparative study in patients with Parkinson's disease
    Lee, CS
    Samii, A
    Sossi, V
    Ruth, TJ
    Schulzer, M
    Calne, DB
    Stoessl, AJ
    NEUROLOGY, 1999, 52 (06) : A175 - A175
  • [10] Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease:: A two-year follow-up study
    Bruck, Anna
    Aalto, Sargo
    Nurmi, Elina
    Vahlberg, Tero
    Bergman, Jogen
    Rinne, Juha O.
    MOVEMENT DISORDERS, 2006, 21 (07) : 958 - 963
1234